The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer

Nat Clin Pract Oncol. 2005 Dec;2(12):596-7. doi: 10.1038/ncponc0360.
No abstract available

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Aromatase Inhibitors / administration & dosage
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Disease-Free Survival
  • Female
  • Humans
  • Survival Rate
  • Tamoxifen / administration & dosage
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Tamoxifen